Stick With Pacific Biosciences of California Inc (PACB). The Bull Are Alive And Well
Currently, there are 273.81M common shares owned by the public and among those 241.84M shares have been available to trade. The company’s stock has a 5-day price change of -15.42% and -10.53% over the past three months. PACB shares are trading -7.10% year to date (YTD), with the 12-month market performance down to -73.27% lower. […]
Pacific Biosciences of California Inc (NASDAQ: PACB): Stock That Needs Special Handling
Currently, there are 273.81M common shares owned by the public and among those 241.81M shares have been available to trade. The company’s stock has a 5-day price change of 1.01% and 29.68% over the past three months. PACB shares are trading 9.84% year to date (YTD), with the 12-month market performance down to -74.75% lower. […]
Growing Through Challenges? – Pacific Biosciences of California Inc (PACB)
Currently, there are 273.81M common shares owned by the public and among those 241.81M shares have been available to trade. The company’s stock has a 5-day price change of 6.99% and 15.70% over the past three months. PACB shares are trading 8.74% year to date (YTD), with the 12-month market performance down to -78.01% lower. […]
Look For Institutional Buying In Pacific Biosciences of California Inc (NASDAQ: PACB)
Pacific Biosciences of California Inc (PACB) concluded trading on Tuesday at a closing price of $1.83, with 7.14 million shares of worth about $13.08 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 42.97% during that period and on December 31, 2024 the price […]
Assessing Whether Pacific Biosciences of California Inc (NASDAQ: PACB) Is Over- Or Undervalued
Pacific Biosciences of California Inc (PACB) concluded trading on Tuesday at a closing price of $1.95, with 2.55 million shares of worth about $4.98 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 43.91% during that period and on December 24, 2024 the price […]
Pacific Biosciences of California Inc (NASDAQ: PACB): The Best-Of-Breed For Investing?
Currently, there are 273.81M common shares owned by the public and among those 241.81M shares have been available to trade. The company’s stock has a 5-day price change of -3.45% and 5.95% over the past three months. PACB shares are trading -80.02% year to date (YTD), with the 12-month market performance down to -77.88% lower. […]
Pacific Biosciences of California Inc (NASDAQ: PACB) Hogging The Spotlight Today
Currently, there are 273.81M common shares owned by the public and among those 262.20M shares have been available to trade. The company’s stock has a 5-day price change of 12.95% and 25.29% over the past three months. PACB shares are trading -77.78% year to date (YTD), with the 12-month market performance down to -73.99% lower. […]
Growing Through Challenges? – Pacific Biosciences of California Inc (PACB)
Currently, there are 267.44M common shares owned by the public and among those 253.36M shares have been available to trade. Insiders at the company have transacted a total of 19 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
Pacific Biosciences of California Inc (NASDAQ: PACB) – Suitable For Long Term Buy?
Currently, there are 267.44M common shares owned by the public and among those 256.44M shares have been available to trade. Insiders at the company have transacted a total of 21 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
These Numbers Could Change Investor Views For Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 267.44M common shares owned by the public and among those 256.44M shares have been available to trade. Insiders at the company have transacted a total of 21 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]